GLP-1 Weight Loss Cost in 2026 — and How to Pay Far Less

Sticker prices for GLP-1 weight loss drugs run as high as $1,349 a month, yet almost nobody who shops smart pays that. This guide breaks down what every FDA-approved GLP-1 actually costs — with and without insurance — then maps the cheapest legitimate routes, from manufacturer savings cards and coupons to compounded telehealth programs starting at $25/month, so you can match the right drug to your budget instead of overpaying.

Julian Caraulani
Julian Caraulani
Dr. A. Goher, MD
Medically reviewed by Dr. A. Goher, MD
Published:

Quick Answer

What you pay for a GLP-1 swings from $25 to $1,349 a monthdepending entirely on how you buy it. With commercial insurance plus a manufacturer savings card, weekly injections like Wegovy or Zepbound can land near $25–$150. Without coverage, compounded semaglutide through telehealth starts around $149, while brand-name list prices top out around $1,349. Six FDA-approved options exist in 2026, including the new oral Foundayo (orforglipron). Compare the cheapest providers here.

What Are GLP-1 Medications (and Why Are They So Expensive)?

GLP-1 medications are prescription drugs that copy a natural gut hormone, glucagon-like peptide-1, to blunt appetite, slow stomach emptying, and steady blood sugar — and their patent protection is a big reason brand prices stay near four figures.

They started life as type 2 diabetes treatments, but the dramatic weight loss they triggered led to dedicated obesity formulations such as Wegovy (semaglutide) and Zepbound (tirzepatide). By acting on GLP-1 receptors in the brain's appetite centers, they quiet hunger and the persistent “food noise” many people with obesity describe. Because these are still on-patent biologics, manufacturers set high list prices — which is exactly why the rest of this guide focuses on how to pay less.

The newer dual-agonist drugs, Mounjaro and Zepbound, hit both GLP-1 and GIP receptors at once for bigger trial results, and they also sit at the top of the price range. In April 2026 the FDA approved Foundayo (orforglipron), the first non-peptide oral GLP-1 — a pill that skips the needle and could reshape pricing for the roughly 40% of patients who avoid injections.

For a deeper dive into the science, read our complete guide to how GLP-1 medications work, including the latest research on food noise reduction and combining GLP-1s with exercise.

How Much Does Each GLP-1 Cost Without Insurance?

All six FDA-approved GLP-1s carry list prices between $936 and $1,349/month before any coupon or coverage — the cheapest tirzepatide and semaglutide deals live below those numbers, not in this table. Here is the full price-versus-results lineup:

Ozempic
Semaglutide
Manufacturer
Novo Nordisk
Avg Weight Loss
8-14% of body weight
Monthly Cost
$998
Type
Injectable
Wegovy
Semaglutide
Manufacturer
Novo Nordisk
Avg Weight Loss
15-17% of body weight
Monthly Cost
$1,349
Type
Oral + Injectable
Mounjaro
Tirzepatide
Manufacturer
Eli Lilly
Avg Weight Loss
15-22% of body weight
Monthly Cost
$1,023
Type
Injectable
Zepbound
Tirzepatide
Manufacturer
Eli Lilly
Avg Weight Loss
20-22% of body weight
Monthly Cost
$1,060
Type
Injectable
Rybelsus
Semaglutide (oral)
Manufacturer
Novo Nordisk
Avg Weight Loss
5-10% of body weight
Monthly Cost
$936
Type
Oral + Injectable
Saxenda
Liraglutide
Manufacturer
Novo Nordisk
Avg Weight Loss
5-8% of body weight
Monthly Cost
$1,350
Type
Injectable

New in 2026: Foundayo (orforglipron) received FDA approval on April 1, 2026. As the first non-peptide oral GLP-1, it does not require refrigeration and can be taken with food. Read our complete Foundayo/orforglipron guide and oral GLP-1 comparison.

For head-to-head drug comparisons, visit our drug comparison hub featuring detailed matchups like Ozempic vs Wegovy, Ozempic vs Mounjaro, and Wegovy vs Zepbound.

Which GLP-1 Gives You the Most Weight Loss per Dollar?

Expect 15–22% body-weight loss on most GLP-1s, but the value math shifts once you factor in price — the highest-result drugs are also the priciest, so the cheapest route isn't always the best result-per-dollar.

The trial numbers are consistent: semaglutide drugs (Ozempic, Wegovy) land at 15–17% average loss, while the dual-agonist tirzepatide drugs (Mounjaro, Zepbound) reach 20–22%. For someone at 250 pounds, that is roughly 37–55 pounds across 12–18 months — results you'll keep paying a monthly fee to maintain, which is why locking in the lowest price up front matters so much.

Real-world outcomes also stray from the trials, and several factors move both your results and your long-term spend:

  • Genetics:A landmark 2026 study by 23andMe identified 14 genetic variants that predict GLP-1 response. Some people are “super-responders” while others see minimal effect. Read the genetics study breakdown.
  • Exercise: Combining GLP-1s with resistance training can reduce muscle loss by up to 50% and improve body composition significantly. See our exercise guide.
  • Muscle preservation: Without exercise, up to 40% of weight lost on GLP-1s may be lean muscle mass rather than fat. Learn about preventing muscle loss.
  • Duration:Weight loss typically plateaus at 12–18 months. Most clinical benefits require ongoing treatment.

The hidden cost most people overlook is what happens after stopping: studies show roughly 1.8 pounds regained per month and near-total regain in about 18 months — meaning the real budgeting question is the multi-year monthly price, not a one-off. Read our weight regain prevention guide.

The Cheapest Ways to Pay for GLP-1 Weight Loss

Three pricing lanes decide what you pay: $25–$150/month with insurance and a savings card, $149–$499/month for compounded telehealth, or $900–$1,349/month at full cash list price.Pick the wrong lane and you can overpay by more than $1,000 a month.

$25–$150
With Insurance
Commercial plans + savings cards
$149–$499
Compounded
Not FDA-approved formulations
$900–$1,349
List Price (Cash)
Without any coverage or discounts
Starting July 2026

Medicare GLP-1 Coverage

The Medicare GLP-1 Bridge program covers Wegovy and Zepbound at $50/month for Part D enrollees starting July 1, 2026. Full coverage under the BALANCE Model begins January 2027.

Read the complete Medicare guide

Side Effects to Budget For Before You Start

Most GLP-1 side effects are gastrointestinal and temporary — nausea (44%), diarrhea (30%), and vomiting (24%) — and they ease as you step up the dose, so they rarely add to your costs.

The same slowed gastric emptying that curbs your appetite is what drives these complaints. Across clinical trials, about 40–70% of people had at least one GI symptom, but the majority faded within the first 4–8 weeks as the body adapted — usually without extra doctor visits or out-of-pocket spend.

44%
Nausea
30%
Diarrhea
24%
Vomiting

Less common but more serious concerns include pancreatitis, gallbladder issues, and a theoretical thyroid cancer risk (observed in rodent studies but not confirmed in humans). The FDA requires a boxed warning about medullary thyroid carcinoma risk on all semaglutide and tirzepatide medications.

Cosmetic side effects have also gained attention, including “Ozempic butt” (sagging skin from rapid fat loss) and facial volume loss sometimes called “Ozempic face.” These are not medically dangerous but reflect the rapid body composition changes these drugs cause.

For a complete breakdown, read our GLP-1 side effects guide and check the latest FDA safety alerts. If you're experiencing side effects, our management strategies guide offers evidence-based tips.

How Do You Find the Cheapest GLP-1 Program?

The lowest-cost GLP-1 program hinges on your insurance, the drug you want, and your state — so we price-checked and independently ranked 32 providers to surface who is actually cheapest.

#1TrimRxEditor's Choice

One-on-one GLP-1 consultations, prescriptions matched to you, and steady doctor support

$179/mo|Compounded Only|45 states
9.3
/10

A LegitScript-verified GLP-1 service with doctors you can name and pay-over-time options

$146/mo|Compounded Only|All 50 states
9.2
/10

A rapidly scaling GLP-1 service offering pills, sublinguals, and shots with Affirm financing

$199/mo|Compounded Only|48 states
9.1
/10

Worried about scams? Use our scam checker tool to verify any provider before signing up. Also read our editorial policy and affiliate disclosure.

GLP-1 Weight Loss Cost: Frequently Asked Questions

What is the cheapest GLP-1 for weight loss?
The cheapest path is commercial insurance plus a manufacturer savings card, which can drop weekly injections to as little as $25/month. If you're uninsured, compounded semaglutide through telehealth is usually the lowest-cost legitimate option, starting around $149/month. Compounded tirzepatide tends to run a bit higher. Medicare enrollees get Wegovy and Zepbound at $50/month from July 2026. Always verify the pharmacy before paying — see our cheapest GLP-1 options guide.
How much is Ozempic without insurance?
Ozempic's cash list price is roughly $936/month, but few people pay that. Without insurance, a Novo Nordisk savings card, a discount card, or switching to compounded semaglutide can cut the bill dramatically — compounded versions often start near $149/month. Costco and other pharmacy memberships occasionally beat retail cash pricing, so it's worth comparing quotes before you fill.
Are GLP-1 coupons and savings cards worth using?
Absolutely — for people with commercial insurance, manufacturer savings cards for Wegovy, Zepbound, Mounjaro, and Ozempic are the single biggest lever, frequently bringing the copay down to $25-$150/month. They typically don't apply to Medicare or Medicaid plans, and each card has monthly and annual caps, so check the fine print. Stacking a savings card with covered insurance is usually the lowest legitimate price available.
Does Medicare cover GLP-1 for weight loss, and what does it cost?
Yes, starting July 1, 2026. The Medicare GLP-1 Bridge program covers Wegovy and Zepbound at $50/month for eligible Part D enrollees with BMI 30+ or BMI 27+ with weight-related conditions. Full Part D coverage arrives January 2027 under the BALANCE Model, and it's expected to help over 7 million beneficiaries who previously had to pay cash.
Why is compounded semaglutide so much cheaper than brand-name?
Compounded semaglutide is mixed by licensed pharmacies rather than the brand manufacturer, which sidesteps brand pricing and lets telehealth programs offer it from around $149/month. The trade-off: compounded versions aren't FDA-approved formulations, quality varies by pharmacy, and availability can change with shortage status. Use a vetted, licensed provider — our scam checker and provider rankings flag which programs are legitimate.
Is the oral GLP-1 pill cheaper than injections?
Not necessarily. Rybelsus (oral semaglutide, available since 2019) carries a list price similar to its injectable cousins for less weight loss (5-10%). Wegovy added an oral pill in January 2026, and Foundayo (orforglipron) — approved April 2026 as the first non-peptide oral GLP-1 — skips the needle and refrigeration but is priced as a premium brand. For now, the cheapest route is still savings-card-discounted injections or compounded semaglutide. See our oral GLP-1 comparison.